for oral mucositis in patients with head and neck cancer: a protocol of a randomised clinical trial.

Introduction: Oral mucositis is an iatrogenic condition of erythematous inflammatory changes which tends to occur on buccal and labial surfaces, the ventral surface of the tongue, the floor of the mouth and the soft palate of patients receiving chemotherapy. This protocol of ongoing randomised parallel group clinical trial aims to access the therapeutic effect of an herbal gel containing 2.5% Verlot standardised extract on oral mucositis in patients with head and neck cancer compared with low-level laser therapy.